Teva Gets Fed. Circ. To Affirm Thyroid Patent Is Indefinite
A Delaware federal judge rightly found that claims of a patent covering the thyroid drug Tirosint are invalid as indefinite, the Federal Circuit affirmed Friday in a win for Teva Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article